Onconova Therapeutics announced that the Company expanded its leadership team with the naming of Dr. Victor Moyo as Chief Medical Officer, CMO, and the addition of Meena Arora as Vice President, VP, Global Medical Affairs and Research and Development, R&D. Dr. Moyo joined Onconova as Consulting Chief Medical Officer in August, 2023. Most recently, Arora served as Vice President/Head of Global Medical Affairs – Epidermolysis Bullosa for Amryt Pharma.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on ONTX:
- Onconova announces preclinical Narazaciclib data presented at MCL meeting
- Promising Preclinical Narazaciclib Data Presented at MCL Meeting
- Onconova Therapeutics to Present a Late-Breaking Abstract on Rigosertib at the 2023 EADV Congress
- Onconova Therapeutics to Participate at the H.C. Wainwright 25th Annual Global Investment Conference